Skip to the main content

Preliminary communication

https://doi.org/10.24141/1/10/1/5

SARCOPENIA RISK ASSESSMENT - SARC-F QUESTIONNAIRE

Miljenko Franić ; University of Applied Health Sciences, Zagreb
Tatjana Njegovan Zvonarević ; University of Applied Health Sciences, Zagreb *
Edina Pulić ; University of Applied Health Sciences, Zagreb
Ana Mojsović Ćuić ; University of Applied Health Sciences, Zagreb
Lana Feher Turković ; University of Applied Health Sciences, Zagreb
Mirjana Telebuh ; University of Applied Health Sciences, Zagreb
Ivan Jurak ; University of Applied Health Sciences, Zagreb

* Corresponding author.


Full text: croatian pdf 156 Kb

page 49-56

downloads: 377

cite

Full text: english pdf 156 Kb

page 49-56

downloads: 85

cite


Abstract

The European Working Group on Sarcopenia in Older People 2 (EWGSOP2) proposed an official instrument for assessing the risk of developing sarcopenia. The SARC-F questionnaire (Strength, Assistance in walking, Rising from a chair, Climbing stairs, and Falls) is increasingly used in clinical practices and research on sarcopenia because of its simple and practical application. The questionnaire contains short and understandable questions that exclude the need to measure muscle mass. Sarcopenia is a multifactorial disease increasingly prevalent among the elderly population characterized by progressive loss of muscle strength, mass and function, with poor outcomes such as functional dependence, falls, injuries, institutionalization and mortality. The recognition of sarcopenia as a determinant of poor health in the elderly has emphasized the importance of prompt diagnosis of sarcopenia, helping physicians implement disease prevention and treatment strategies. The paper describes the SARC-F questionnaire, its use and the possibility of risk assessment for the development of sarcopenia.

Keywords

SARC-F questionnaire, sarcopenia, risk assessment

Hrčak ID:

318238

URI

https://hrcak.srce.hr/318238

Publication date:

21.6.2024.

Article data in other languages: croatian

Visits: 850 *